ArticleACS pharmacology & translational science2022

Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2.

Brandon Dale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.